Industry Overview

European oncology information system market was valued at $1.0 billion in 2025 and is projected to reach $2.2 billion by 2035, expanding at a CAGR of 8.1% during the forecast period (2026–2035). Oncology Information Systems (OIS) are advanced healthcare IT platforms that enable the efficient management of cancer patient data, streamline clinical workflows, and support precise treatment planning across oncology departments. These systems integrate radiology, pathology, and electronic health records, allowing healthcare providers to deliver coordinated and data-driven cancer care. The increasing incidence of cancer across Europe, coupled with the rising adoption of digital health technologies and the growing emphasis on precision medicine, is significantly driving market growth. Moreover, healthcare providers are continuously investing in advanced OIS platforms to enhance clinical outcomes, improve operational efficiency, and ensure seamless data integration across multidisciplinary care teams.

Recent technological advancements and strategic developments are further accelerating the adoption of oncology information systems in Europe. In April 2026, Philips Healthcare received FDA 510(k) clearance for its Rembra platform, which includes CT and radiation therapy capabilities designed to improve cancer treatment planning and imaging workflows. The platform enhances diagnostic speed, efficiency, and integration between radiology and radiation therapy, supporting more connected oncology care pathways. Similarly, in March 2026, Siemens Healthineers presented AI-powered imaging systems and digital radiology solutions at the European Congress of Radiology (ECR) 2026 in Vienna. These innovations, including AI-guided angiography systems and integrated digital workflows, aim to improve diagnostic precision and clinical decision-making in oncology. Collectively, such advancements are strengthening data interoperability, treatment accuracy, and workflow automation, while increasing investments in healthcare IT infrastructure and supportive government initiatives continue to drive widespread adoption of oncology information systems across hospitals, cancer treatment centers, and research institutions in Europe.

Market Dynamics

AI-Driven Oncology Software Advancing Treatment Precision

Software segment dominates the market due to its essential role in managing oncology workflows, patient records, and treatment planning. Advanced platforms integrate imaging, diagnostics, and therapy data, enhancing clinical efficiency and patient outcomes. In May 2025, GE HealthCare expanded its radiation oncology portfolio at ESTRO 2025, introducing AI-enabled solutions such as MR Contour DL. These innovations improve treatment planning accuracy, workflow automation, and radiotherapy precision. The development strengthens software adoption in oncology by enabling faster and more efficient cancer care delivery.

Radiation Oncology Driving Application Growth

Radiation oncology is emerging as the fastest-growing application segment, driven by the increasing adoption of precision radiotherapy techniques in cancer treatment. Oncology information systems play a vital role in optimizing treatment planning, dose management, and workflow efficiency within radiation oncology departments. In April 2025, Elekta AB partnered with Azra AI to enhance cancer registry operations through AI-powered automation. The collaboration integrates oncology registry software with real-time workflow tools to improve data management, reporting accuracy, and operational efficiency. This advancement supports the expansion of digital oncology infrastructure and accelerates the adoption of oncology information systems across healthcare settings.

Market Segmentation

• Based on product type, the market is segmented into software and services.
• Based on application, the market is segmented into medical oncology, radiation oncology, and surgical oncology.
• Based on end user, the market is segmented into hospitals, cancer treatment centers, and research & academic institutes.

AI-Driven Hospital Oncology Workflows Transforming Cancer Care

Hospitals continue to lead end-user adoption in the oncology information system market due to their advanced infrastructure and high patient volumes. The growing integration of healthcare IT systems is accelerating the deployment of OIS platforms across hospital settings. In September 2025, Fuse Oncology showcased its AI-powered clinical solutions at the ASTRO 2025, aimed at streamlining radiation oncology workflows. The platform enhances interoperability, improves compliance, and reduces administrative burden, enabling more efficient clinical operations. This advancement is strengthening the adoption of OIS software in hospitals by optimizing workflow integration and improving overall treatment efficiency.

Regional Outlook

The European oncology information system market is further divided by region, including the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe.

Germany is the leading county in Europe Oncology Information System Market

Germany leads the Europe Oncology Information System Market due to its well-established healthcare infrastructure, rising cancer burden, and strong adoption of digital health technologies. In November 2025, Philips Healthcare launched a next-generation web-based diagnostic viewer under its Image Management platform, enabling hospitals to securely access and analyze imaging data through a browser-based interface. The solution incorporates AI-driven tools and advanced reporting workflows to enhance clinical collaboration and streamline operations. It also reduces IT complexity while accelerating decision-making across healthcare facilities. This development supports the growing adoption of oncology information system software in hospitals by improving imaging integration and workflow efficiency.

Market Players Outlook

The major companies operating in the European oncology information system market include McKesson Corporation, Siemens Healthineers, GE HealthCare, Philips Healthcare, and Oracle Health, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisitions to expand their businesses and develop innovative products, maintaining their market positioning.

Recent Development

• In May 2025, Siemens Healthineers and Varian Medical Systems showcased integrated oncology innovations at ESTRO 2025, including advanced radiotherapy planning solutions and AI-enabled workflows. The portfolio highlighted improved interoperability through solutions like Oncology Exchange, enabling seamless data transfer across imaging and treatment systems. These advancements enhance hospital-based radiation oncology workflows and support the adoption of oncology information systems across European healthcare settings.

• In May 2024, GE HealthCare launched AI-enhanced personalized oncology solutions at the ESTRO 2024 Congress, including the Revolution RT platform and an upgraded Intelligent Radiation Therapy (iRT) system. These solutions integrate advanced imaging, AI-driven workflows, and multi-system interoperability to optimize radiation oncology processes and improve treatment precision. The innovation supports the adoption of oncology information system software in hospitals by enhancing workflow efficiency, data integration, and personalized cancer care pathways.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the European oncology information system market
• Based on the availability of data, information related to new protections and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.